Results 121 to 130 of about 4,485 (161)

From medicine price control to deregulation: assessing policy effects on insulin access in Pakistan's private pharmacies. [PDF]

PLoS One
Saeed A, Jiang M, Ali Yasin N, Zhao J, Yang C, Fang Y, Babar ZU.   +6 more
europepmc   +1 more source

Comparative Association of Basal and Basal-Prandial Insulin Regimens on Remnant Cholesterol and Lipid Profiles in Patients with Type 2 Diabetes Mellitus. [PDF]

Diabetes Metab Syndr Obes
Natsir RM, Halimah E, Diantini A, Levita J, Umar H.   +4 more
europepmc   +1 more source

First Dimension Trap-and-Elute Combined with Second Dimension Reversed-Phase Liquid Chromatography Separation Using a Two-Dimensional-Liquid Chromatography-Tandem Mass Spectrometry System for Sensitive Quantification of Human Insulin and Six Insulin Analogs in Plasma: Improved Chromatographic Resolution and Stability Testing. [PDF]

J Sep Sci
Sistik P, Urinovska R, Handlosova K, Handlos P, Andelova K, Jurica J, Stejskal D.   +6 more
europepmc   +1 more source

Antidiabetic drug utilization pattern, affordability and cost analysis in Iran from 2009 to 2021: A need to revise guideline. [PDF]

PLoS One
Zartab S, Abbasian H.
europepmc   +1 more source

Incretin-based injectable strategies versus intensified insulin for treatment intensification and simplification in type 2 diabetes: a systematic review and meta-analysis. [PDF]

J Diabetes Metab Disord
Mahmood T, Myrtziou I, Kanakis I.
europepmc   +1 more source

A Case of Insulin Edema Syndrome Improved by Weekly Insulin. [PDF]

JCEM Case Rep
Desgagnés N, Talos L, Pasqua MR, Tardio V.   +3 more
europepmc   +1 more source

Insulin edema in slowly progressive type 1 diabetes: improvement following adjustment of insulin therapy. [PDF]

Diabetol Int
Okamura E, Harada N, Okuno K, Yamamoto K, Murakami T, Ueda Y, Yabe D.   +6 more
europepmc   +1 more source

Low prevalence of GCK gene mutations in Chinese patients with gestational diabetes mellitus. [PDF]

Clinics (Sao Paulo)
Wang Z, Huo L, Lan L, Chen Y, Zuo Q, Deng W.   +5 more
europepmc   +1 more source

Cost-Effectiveness analysis of insulin therapies for patients with type 2 diabetes in Iran: a long-term analysis using the UKPDS model. [PDF]

J Diabetes Metab Disord
Darvishi A, Daroudi R, Dehghan S, Shafiee G, Ostovar A, Heshmat R.   +5 more
europepmc   +1 more source

Emerging Insulin Analogues: A Glimpse into How Insulin Analogues May Look in the near Future. [PDF]

Pharmaceutics
Sibiya N, Dzimwasha L, Zvandasara S, Zuma A, Khathi A.   +4 more
europepmc   +1 more source